OB/GYN

In a presentation at the Nurse Practitioners in Women’s Health (NPWH) 25th Annual Conference, Katie Huffling DNP, RN, CNM, FAAN, explained how different cases of environmental exposure are impacting women’s health.

If approved, ibrexafungerp would be the first and only approved therapy for both the treatment of vulvovaginal candidiasis (VVC) and the prevention of recurrent vulvovaginal candidiasis (RVVC).

What we know about monkeypox in pregnancy, including treatment recommendations, vaccination, and postpartum care.

Perrigo’s HRA Pharma has submitted an application to the US Food and Drug Administration (FDA) for possible future approval of the first-ever OTC birth control pill.

Prenatal exposure to the antiseizure medications topiramate and valproate may cause a significantly increased risk of neurodevelopmental disorders in offspring, according to a cohort study in JAMA Neurology.

A retrospective study found that postmenarchal women with a renal anomaly were also at risk of having a Müllerian anomaly.

The increase was highest for Hispanic and non-Hispanic Black Women.

With the Supreme Court's overturning of Roe v Wade eliminating the constitutional right to an abortion, there are questions about its impact on fertility care.

Understanding signs, symptoms helps determine the best treatment regimen.

The American Medical Association is urging the FDA to approve OTC access to oral contraceptives.

Period poverty isn’t just an issue in third-world countries or among low-income women. Across the United States, women of all ages still struggle to afford menstrual products.

Vaginal yeast infections were successfully treated with berberine, a biologically active herbal alkaloid, according to a study published in Frontiers in Pharmacology.

Postpartum psychosis is experienced by 1 to 2 women every 1000 deliveries.

A recent study showed that patients with atopic dermatitis have a higher prevalence of infertility, highlighting the need for clinicians to be wary of this increased risk and improve the care and management of this patient population.

Research from the Developing Brain Institute found maternal psychological distress during the COVID-19 pandemic had disrupted critical processes of fetal brain development.

Currently approved for the treatment of vulvovaginal candidiasis, and if the sNDA is approved, ibrexafungerp would be the first and only oral non-azole medication for the prevention of recurrent VVC.

The FDA recently announced the acceptance of a supplemental New Drug Application for relugolix 40 mg, estradiol 1 mg, and norethindrone acetate .5 mg in the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.

Offering an inclusive, safe space along with the best care for transgender and nonbinary adolescent patients is more important than ever.

Pediatric adolescent gynecologic topics are critical to the practice, and patient families.

COVID-19 vaccination during pregnancy may reduce infants’ risk of infection during the early months of life, according to a recent study.

Part 2 in a series on emergencies in pediatric and adolescent gynecology.

An undocumented, Spanish-speaking, 15-year-old female presented to the emergency department with 3 weeks of fever (>101℉) and 3 days of abdominal pain. What's the diagnosis?

Kenneth J. Tomecki, MD, discussed the clinical relevance of sexually transmitted diseases to dermatology and outlined what to look for and how to treat various conditions at the 2022 Fall Clinical Dermatology Conference for PAs & NPs.

Counseling patients about methods of contraception and increasing access to care can help address unplanned pregnancies and sexually transmitted diseases.

While antibiotic dosing was correct, therapy duration was frequently inappropriate.

Part 1 in a series on emergencies in pediatric and adolescent gynecology.

Recommendations are often vague, contradictory, according to investigators.

When helping patients in the hardest moments of their lives, it is important to have empathy for them—and for ourselves.

A presentation at the 2022 American College of Obstetricians and Gynecologists’ Annual Clinical & Scientific Meeting discussed the recent updates in contraceptives including new nonhormonal intrauterine devices.

A prospective cohort study examines whether higher childhood body mass index (BMI) was linked to a greater risk of premenstrual symptoms in young adulthood compared than children with lower BMIs.